company background image
6242 logo

Li Kang Biomedical TPEX:6242 Stock Report

Last Price

NT$54.20

Market Cap

NT$1.5b

7D

1.3%

1Y

1.0%

Updated

28 Mar, 2024

Data

Company Financials

Li Kang Biomedical Co., Ltd.

TPEX:6242 Stock Report

Market Cap: NT$1.5b

6242 Stock Overview

Li Kang Biomedical Co., Ltd. manufactures and sells supplement, cosmeceutical, and hygienic drink products.

6242 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends3/6

Li Kang Biomedical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Li Kang Biomedical
Historical stock prices
Current Share PriceNT$54.20
52 Week HighNT$71.30
52 Week LowNT$52.17
Beta0.30
1 Month Change-1.99%
3 Month Change-7.03%
1 Year Change1.02%
3 Year Change57.32%
5 Year Change32.89%
Change since IPO-81.89%

Recent News & Updates

Recent updates

Li Kang Biomedical (GTSM:6242) Has Some Way To Go To Become A Multi-Bagger

Apr 19
Li Kang Biomedical (GTSM:6242) Has Some Way To Go To Become A Multi-Bagger

Is Li Kang Biomedical Co., Ltd. (GTSM:6242) A Smart Choice For Dividend Investors?

Mar 09
Is Li Kang Biomedical Co., Ltd. (GTSM:6242) A Smart Choice For Dividend Investors?

Li Kang Biomedical Co., Ltd.'s (GTSM:6242) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Feb 09
Li Kang Biomedical Co., Ltd.'s (GTSM:6242) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

The Trends At Li Kang Biomedical (GTSM:6242) That You Should Know About

Jan 19
The Trends At Li Kang Biomedical (GTSM:6242) That You Should Know About

We Think Li Kang Biomedical (GTSM:6242) Can Stay On Top Of Its Debt

Dec 29
We Think Li Kang Biomedical (GTSM:6242) Can Stay On Top Of Its Debt

Three Things You Should Check Before Buying Li Kang Biomedical Co., Ltd. (GTSM:6242) For Its Dividend

Dec 08
Three Things You Should Check Before Buying Li Kang Biomedical Co., Ltd. (GTSM:6242) For Its Dividend

Shareholder Returns

6242TW Personal ProductsTW Market
7D1.3%1.7%1.9%
1Y1.0%-9.0%26.7%

Return vs Industry: 6242 exceeded the TW Personal Products industry which returned -9% over the past year.

Return vs Market: 6242 underperformed the TW Market which returned 26.7% over the past year.

Price Volatility

Is 6242's price volatile compared to industry and market?
6242 volatility
6242 Average Weekly Movement2.5%
Personal Products Industry Average Movement3.4%
Market Average Movement4.2%
10% most volatile stocks in TW Market8.0%
10% least volatile stocks in TW Market1.9%

Stable Share Price: 6242 has not had significant price volatility in the past 3 months.

Volatility Over Time: 6242's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1982122n/ahttps://www.likangbio.com

Li Kang Biomedical Co., Ltd. manufactures and sells supplement, cosmeceutical, and hygienic drink products. It also engages in the management and consulting of tourism factory business; and offers telemarketing services. The company was formerly known as BAFO Technologies Corporation and changed its name to Li Kang Biomedical Co., Ltd.

Li Kang Biomedical Co., Ltd. Fundamentals Summary

How do Li Kang Biomedical's earnings and revenue compare to its market cap?
6242 fundamental statistics
Market capNT$1.45b
Earnings (TTM)NT$110.99m
Revenue (TTM)NT$629.38m

13.1x

P/E Ratio

2.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6242 income statement (TTM)
RevenueNT$629.38m
Cost of RevenueNT$203.23m
Gross ProfitNT$426.15m
Other ExpensesNT$315.15m
EarningsNT$110.99m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)4.14
Gross Margin67.71%
Net Profit Margin17.64%
Debt/Equity Ratio5.6%

How did 6242 perform over the long term?

See historical performance and comparison

Dividends

3.2%

Current Dividend Yield

40%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.